Finance

Beta
Ask
Lists
SRTA:NASDAQ
Strata Critical Medical Inc
$5.88
+1.55%
(+0.090) 1D
$5.88
0.00% (0.00)
After hours
Closed: Jun 18, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SRTA...
Open
$5.88
High
$5.98
Low
$5.67
Mkt. cap
508.78M
Avg. vol.
1.19M
Volume
2.67M
P/E ratio
10.32
52-wk high
$6.50
52-wk low
$3.58
EPS
$0.57
Beta
2.20
Shares outstanding
86.53M
No. of employees
327
Open
$5.88
High
$5.98
Low
$5.67
Mkt. cap
508.78M
Avg. vol.
1.19M
Volume
2.67M
P/E ratio
10.32
52-wk high
$6.50
52-wk low
$3.58
EPS
$0.57
Beta
2.20
Shares outstanding
86.53M
No. of employees
327
Analyst outlook
Analyst Ratings
Based on 4 analysts giving stock ratings to SRTA in the past 3 months
Strong Buy
Buy
4
Hold
0
Sell
0
12 month forecast
Based on 4 Wall Street analysts offering 12 month price targets for SRTA in the last 3 months.
Highest
Current $5.88
$11.50 (+95.58%)
Average
$9.17 (+55.95%)
Lowest
$8.00 (+36.05%)
Profile
Blade Air Mobility, Inc. is an aviation company headquartered in New York City and incorporated in Delaware. Blade's urban air mobility platform provides air transportation for passengers and last-mile critical cargo, primarily using helicopters and amphibious aircraft for passenger routes in the United States, Canada, Southern Europe, and India, in addition to being one of the largest air medical transporters of human organs for transplant in the world. Blade began trading on the Nasdaq on May 10, 2021, via a SPAC merger. Wikipedia
About Strata Critical Medical Inc
CEO-
Employees327
FoundedMay 2014
Headquarters-
SectorHealth care provider
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
70.80M
49.30M
66.79M
67.38M
Cost of goods sold
-
37.68M
55.12M
53.27M
Cost of revenue
-
37.68M
55.12M
53.27M
Research and development expenses
-
453.00K
-1.35M
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
11.74M
13.99M
14.54M
Operating expense
-
12.19M
15.24M
16.02M
Total operating expenses
-
49.88M
70.35M
69.29M
Operating income
-
-577.00K
-3.57M
-1.90M
Other non operating income
-
33.00K
1.42M
1.46M
EBT including unusual items
-
-9.66M
-5.39M
2.40M
EBT excluding unusual items
-
583.00K
-1.51M
27.00K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-
57.42M
-8.83M
2.15M
Net profit margin
-
116.47%
-13.23%
3.20%
Earnings per share
-0.04
-
-
0.04
Interest and investment income
-
1.13M
638.00K
473.00K
Interest expense
-
-
-
-
Net interest expenses
-
1.13M
638.00K
473.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-158.00K
-558.00K
1.16M
Gain or loss from assets sale
-
-60.44M
-
344.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more